JDJohannes Devos

Johannes Devos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Johannes Devos has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improving outcome prediction in oropharyngeal carcinoma through the integration of diffusion-weighted magnetic resonance imaging radiomics

    by Heleen Bollen, Rüveyda Dok, Frederik De Keyzer, Sarah Deschuymer, Annouschka Laenen, Johannes Devos, Vincent Vandecaveye, Sandra Nuyts


  • Open Access

    Diffusion-Weighted MRI and Human Papillomavirus (HPV) Status in Oropharyngeal Cancer

    by Heleen Bollen, Rüveyda Dok, Frederik De Keyzer, Sarah Deschuymer, Annouschka Laenen, Johannes Devos, Vincent Vandecaveye, Sandra Nuyts

    Background: This study aimed to explore the differences in quantitative diffusion-weighted (DW) MRI parameters in oropharyngeal squamous cell carcinoma (OPC) based on Human Papillomavirus (HPV) status before and during radiotherapy (RT). Methods: Echo planar DW sequences acquired before and during (chemo)radiotherapy (CRT) of 178 patients with histologically proven OPC were prospectively analyzed. The volumetric region of interest (ROI) was manually drawn on the apparent diffusion coefficient (ADC) map, and 105 DW-MRI radiomic parameters were extracted. Change in ADC values (Δ ADC) was calculated as the difference between baseline and during RT at week 4, normalized by the baseline values. Results: Pre-treatment first-order 10th percentile ADC and Gray Level co-occurrence matrix (GLCM)-correlation were significantly lower in HPV-positive compared with HPV-negative tumors (82.4 × 10−5 mm2/s vs. 90.3 × 10−5 mm2/s, p = 0.03 and 0.18 vs. 0.30, p < 0.01). In the fourth week of RT, all first-order ADC values were significantly higher in HPV-positive tumors (p < 0.01). Δ ADC mean was significantly higher for the HPV-positive compared with the HPV-negative OPC group (95% vs. 55%, p < 0.01). A predictive model for HPV status based on smoking status, alcohol consumption, GLCM correlation, and mean ADC and 10th percentile ADC values yielded an area under the curve of 0.77 (95% CI 0.70–0.84). Conclusions: Our results highlight the potential of DW-MR imaging as a non-invasive biomarker for the prediction of HPV status, although its current role remains supplementary to pathological confirmation.


  • Spontaneous Intrathyroidal Hemorrhage—A Rare Potential Life-Threatening Condition

    by Sébastien Selleslag, Jeroen Meulemans, Robert Hermans, Johannes Devos

    Thyroid nodules and cysts, while typically benign, can occasionally result in severe complications such as acute intrathyroidal hemorrhage, leading to hematoma formation and airway compromise. This report details the case of a 70-year-old female with a history of a multinodular goiter, presenting with sudden-onset dysphagia, dyspnea, and retrosternal pain. Imaging revealed significant tracheal compression due to a large hematoma caused by a ruptured thyroid cyst. Urgent surgical intervention, including left hemithyroidectomy and hematoma drainage, alleviated the airway obstruction. This case underscores the importance of early recognition and intervention in rare but potentially life-threatening thyroid complications. Further research is needed to elucidate the mechanisms of spontaneous intrathyroidal hemorrhage and improve management strategies. Cite this article as: Selleslag S, Meulemans J, Hermans R, Devos J. Spontaneous intrathyroidal hemorrhage—a rare potential life-threatening condition. B-ENT. 2024;20(4):269-271.


  • Open Access

    The Imaging Appearance of EWSR1::PATZ1 Gene Fusion Central Nervous System Tumors

    by Cedric Vanmarcke, Lukas Marcelis, Isabelle Vanden Bempt, Raf Sciot, Johannes Devos

    Ewing Sarcoma Breakpoint Region 1 and POZ/BTB And AT Hook Containing Zinc Finger 1 (EWSR1::PATZ1) gene fusion central nervous system (CNS) tumors are increasingly recognized as a potential distinct entity, with only limited reported cases. The imaging characteristics of these tumors have not been well established. In this study, we provide a detailed radiological description of a case in a 24‑year‑old man and conduct a literature review to identify common imaging features.


  • Open Access

    Tophaceous Gout of the Middle Ear

    by Joren Waumans, Christian Desloovere, Johannes Devos

    Tophaceous gout can rarely present in the middle ear as a mass-like lesion, causing conductive hearing loss. Noncontrast high-resolution computed tomography (HRCT) of the temporal bone plays a significant role in the diagnosis. Awareness of this condition among radiologists is important since it presents with a distinctive appearance on HRCT. We present a case of tophaceous gout of the middle ear diagnosed with photon-counting computed tomography (PCCT). Teaching point: The presence of a partially calcified mass with ground-glass components or with a semolina-like appearance within the middle ear is highly suggestive of tophaceous gout, even in the presence of normal serum uric acid levels.


  • Fetal-onset Alexander disease with radiological-neuropathological correlation

    by Johannes Devos, Koenraad Devriendt, Jute Richter, Katrien Jansen, Marcella Baldewijns, Dietmar R. Thal, Michael Aertsen

    Alexander disease is a leukodystrophy caused by mutations in the GFAP gene, primarily affecting the astrocytes. This report describes the prenatal and post-mortem neuroimaging findings in a case of genetically confirmed, fetal-onset Alexander disease with pathological correlation after termination of pregnancy. The additional value of fetal brain magnetic resonance imaging in the third trimester as a complementary evaluation tool to neurosonography is shown for suspected cases of fetal-onset Alexander disease. Diffuse signal abnormalities of the periventricular white matter in association with thickening of the fornix and optic chiasm can point towards the diagnosis. Furthermore, the presence of atypical imaging findings such as microcephaly and cortical folding abnormalities in this case broadens our understanding of the phenotypic variability of Alexander disease. Graphical Abstract


  • Neuro-image: recurrent painful ophthalmoplegic neuropathy

    by Johannes Devos, Céline Nysten, Gunnar Buyse, Catherine Cassiman, Philippe Demaerel


  • Open Access

    Residual Splenic Volume after Main Splenic Artery Embolization is Independent of the Underlying Disease

    by Johannes Devos, Lawrence Bonne, Sandra Cornelissen, Walter Coudyzer, Wim Laleman, Chris Verslype, Willem-Jan Metsemakers, Geert Maleux

    To assess the safety and efficacy of main splenic artery embolization. To assess the potential difference post-embolization of the residual splenic volume in patients embolized for trauma versus those embolized for (pseudo)aneurysms. A retrospective analysis was performed on a cohort of 65 patients (36 males) who underwent pre- and post-embolization computed tomography. Patients’ demographics, pre- and post-interventional medical and radiological data were gathered. Splenic volume calculations were semi-automatically performed via a workstation. Patients with splenic aneurysms or pseudoaneurysms of the main splenic artery (group 1) were compared to those with splenic rupture (group 2) using Wilcoxon rank tests. The main indications for splenic artery embolization were splenic rupture (n = 22; 34%) and splenic pseudoaneurysm (n = 19; 29%). The technical success rate was n = 63; 97%. The procedure-related complication rate was n = 7; 11%, including abscess formation (n = 5; 8%), re-bleeding (n = 1; 1.5 %) and pseudoaneurysm re-opening (n = 1; 1.5%). The overall 30-day mortality was n = 7; 11%. Median follow-up for groups 1 and 2 was 1163 days (61–3946 days) and 702 days (43–2095 days) respectively. When processable (n = 23), the splenic volume in group 1 (n = 7) was 311 cm3 and 257 cm3 (p = 0.1591) before and after embolization respectively, and in group 2 (n = 16) it was 261 cm3 and 215 cm3 (p = 0.4688), respectively. Main splenic artery embolization is efficacious, with low procedure-related complication and 30-day mortality rates. No significant differences in residual post-embolization splenic volume were found between patients treated for splenic rupture versus those treated for splenic arterial (pseudo)aneurysm.